Skip to main content

Table 3 Comparison of logMAR BCVA between Ozurdex and triamcinolone at each follow up visit

From: Intravitreal dexamethasone implant versus triamcinolone acetonide for macular oedema of central retinal vein occlusion: quantifying efficacy and safety

  Ozu (n = 20) logmar BCVA-median Versus baseline; P value Tri (n = 20) logmar BCVA-median Versus baseline; P value Ozu versus Tri P value
Baseline 1.079 1.0395 0.3920
4 weeks 0.778 0.107* 0.778 0.0107* 0.9071
8 weeks 0.602 0.0352* 0.602 0.0246* 1.0000
12 weeks 0.477 0.0208* 0.477 0.0188* 0.6990
24 weeks 0.477 0.0179* 0.389 0.0142* 0.5828
  1. *Statistically significant